Penuma Photos: What Before-and-After Images Don’t Show About Results
Introduction: The Problem With Penuma Photos
Men researching Penuma—now rebranded as Himplant—instinctively search for before-and-after photos. This represents a natural, rational first step when evaluating a high-stakes, high-cost decision that could permanently alter one’s body. The impulse to seek visual proof makes complete sense.
The photos are real. Clinical studies confirm meaningful girth increases, with the landmark 2018 Journal of Sexual Medicine study of 400 patients documenting a 56.7% midshaft circumference increase. These results are not fabricated or digitally enhanced.
However, before-and-after images represent a deliberately curated slice of a much larger clinical story. They showcase the best outcomes while omitting complication rates, post-explant consequences, recovery realities, and how non-surgical alternatives compare visually. This selective presentation leaves men making decisions with incomplete information.
This article provides a clinically grounded, honest resource that decodes what Penuma photos reveal, what they omit, and why a growing number of men ultimately choose a non-surgical path with comparable visual outcomes and a fraction of the risk.
What Penuma Photos Actually Show: The Clinical Reality Behind the Images
Penuma, now marketed as Himplant, holds the distinction of being the first and only FDA-cleared penile implant for cosmetic enhancement, receiving FDA 510(k) clearance in 2004. The device is a U-shaped soft silicone sleeve inserted subcutaneously through a small scrotal incision under general anesthesia in a 45–60 minute outpatient procedure.
Three sizes are available—Large (L), Extra-Large (XL), and Extra-Extra-Large (XXL)—with custom fitting based on individual anatomy. This sizing context is something photos alone cannot convey.
The peer-reviewed visual outcomes are legitimate. The 2018 study documented a 56.7% midshaft circumference increase. A 2024 study published in Therapeutic Advances in Urology found average flaccid length increases of 2.5 cm (44%) and girth increases of 3.1 cm (32%). A multi-institutional 2024 study showed a 50% flaccid length increase and 36.9% girth increase.
Notably, 82% of patients in the 2024 study reported satisfaction with postoperative penile appearance—a strong number that simultaneously implies 18% were not satisfied.
Official Penuma photos are hosted on penuma.com and certified provider clinics, gated behind age and consent confirmations. Peer-reviewed clinical photos on platforms like ResearchGate represent the highest-authority visual references but remain largely inaccessible to general consumers.
What Penuma Photos Deliberately Omit
Photos are selected from satisfied patients. They structurally exclude men who experienced complications, required revision, or underwent explantation.
Complication Rates the Images Don’t Capture
The original 2018 study documented complication rates including seroma (4.8%), scar formation (4.5%), and infection (3.3%). A 2023 multi-institutional study found infection at 0.6%, seroma at 1.2%, erosion at 3.6%, and 5.9% unsatisfactory cosmetic results requiring revision.
The 2024 multi-institutional update found erosion risk higher than previously reported—a concerning trend that photos never reveal.
The scrotal lateral incision approach shows significantly lower revision rates (2% vs. 13%) and removal rates (6% vs. 21%) compared to the traditional infrapubic approach. This critical distinction remains invisible in photographs.
The Sexual Medicine Society of North America (SMSNA) has formally recommended that Penuma implants only be performed under IRB-approved research protocols due to concerns about severe complications in young patients with no underlying sexual dysfunction.
Post-Explant Consequences: The Photos That Are Never Shown
A 2025 Journal of Sexual Medicine paper provides the most current and sobering clinical data on what happens when Penuma must be removed.
Distal protrusion accounts for 63% of explant cases as the leading reason for device removal. The post-explant complication profile is severe: dorsal curvature occurs in 67% of removal cases and penile shortening in 58%. These outcomes are permanent, disfiguring, and never depicted in any promotional before-and-after gallery.
The AUA Journal of Urology has published complication case series confirming post-explant dorsal curvature due to capsule contraction. The International Journal of Impotence Research introduced a penile rehabilitation program specifically for post-explant patients—underscoring that this is a recognized clinical problem requiring specialized intervention.
Recovery Reality: What the “After” Photo Doesn’t Show
The “after” photo represents a healed, recovered state—not the 6–8 week journey required to reach it.
Recovery requirements include general anesthesia, 6–8 weeks of mandatory sexual abstinence post-surgery, and significant downtime that poses challenges for professionals with demanding schedules.
The cost barrier is substantial: $10,500–$19,000 (most commonly $15,000–$18,000), not covered by insurance.
Contraindications that photos never address include restrictions for uncircumcised men, smokers, men with prior penile cosmetic surgery (including HA, PMMA, or fat injections), and those with conditions impairing wound healing.
By contrast, non-surgical alternatives allow patients to return to normal activities in 10 days, resume sexual activity within 7–10 days, require no general anesthesia, and are completed as outpatient procedures in under one hour.
The Comparison Gap: Filler Results vs. Penuma Results
The most significant content gap across existing resources is the absence of direct side-by-side visual comparisons of Penuma implant results versus penile filler results with equivalent girth outcomes.
Clinical data on non-surgical filler outcomes is compelling. A 2025 Journal of Sexual Medicine single-center study of 324 patients found 89% patient satisfaction and a mean girth increase of 2.5 cm—directly comparable to Penuma’s reported girth gains.
A 2022 randomized controlled trial in the World Journal of Men’s Health documented mean girth increases of approximately 22 mm with hyaluronic acid filler and no serious adverse events. A 2023 meta-analysis found HA filler superior to polylactic acid for penile diameter increase and post-augmentation sexual satisfaction.
The 2025 Translational Andrology and Urology review concluded that low-volume HA via standardized protocol may be the safest modality for appropriately counseled and selected patients.
When girth outcomes are clinically comparable, the decision framework shifts entirely to risk, recovery, reversibility, and cost—all factors that photos cannot communicate.
Hyaluronic Acid Filler vs. Penuma: A Clinical Comparison Beyond the Photos
A clear, credible comparison framework spanning five dimensions—girth outcomes, safety profile, reversibility, recovery timeline, and cost—serves men evaluating these options.
Girth Outcomes: Comparable Results, Different Mechanisms
Penuma delivers a 32–56.7% girth increase depending on study and measurement point, achieved through a permanent silicone implant.
HA filler provides a mean 2.5 cm girth increase (2025 JSM study) and 22 mm increase (2022 WJMH RCT). The collagen-stimulating filler approach used by practices like Stoller Medical Group achieves 80–90% permanent improvement in girth and volume, with results lasting 18–24 months and touch-up options available.
For men seeking moderate, natural-looking enhancement rather than maximum size, filler outcomes are clinically equivalent—and results appear natural in both flaccid and erect states.
Safety Profile: Surgical Risk vs. Injectable Risk
Penuma requires general anesthesia and carries the following risks across studies: infection (0.6–3.3%), seroma (1.2–4.8%), erosion (up to 3.6%), revision rates up to 13% (infrapubic approach), removal rates up to 21% (infrapubic approach), post-explant dorsal curvature in 67% of cases, and penile shortening in 58%.
HA filler requires no anesthesia, showed no serious adverse events in the 324-patient 2025 JSM study, remains reversible with hyaluronidase enzyme if needed, involves no surgical incision, and has no reported cases of permanent disfigurement in peer-reviewed literature when performed by qualified providers.
The SMSNA’s IRB-only recommendation, post-explant complication data, and 6–8 week recovery requirement are increasingly accessible in peer-reviewed literature—and increasingly influencing patient decisions. The 2025 Translational Andrology and Urology review explicitly identifies low-volume HA as the safest modality across all penile enhancement options.
Reversibility, Recovery, and Real-World Practicality
Reversibility: HA filler can be dissolved with hyaluronidase—a critical safety net. Penuma explantation carries a 67% risk of dorsal curvature and 58% risk of penile shortening.
Recovery: Penuma requires 6–8 weeks of sexual abstinence and significant downtime under general anesthesia. Filler procedures take under one hour as outpatient visits, with return to sexual activity in 7–10 days.
Cost: Penuma runs $15,000–$18,000, not covered by insurance, as a single procedure. Filler offers a significantly lower upfront cost, a staged treatment approach, and optional periodic touch-ups.
Stoller Medical Group has performed over 15,000 procedures, establishing clinical expertise that rivals or exceeds many surgical programs in volume.
How to Evaluate Before-and-After Photos Critically
A practical framework for evaluating any before-and-after photo gallery—surgical or non-surgical—helps men make more informed decisions.
Key questions to ask:
- What percentage of treated patients are represented in the gallery?
- What is the complication rate for the full patient population?
- Are post-explant or post-complication outcomes shown?
- What is the follow-up timeline for the “after” photo?
Red flags in photo galleries: Only flaccid state shown, no scale reference, no disclosure of patient selection criteria, no mention of revision or removal rates.
Green flags: Photos accompanied by clinical study citations, disclosure of complication rates, multiple follow-up timepoints, and documentation of both flaccid and erect states.
Peer-reviewed clinical photos represent the highest-authority visual references—and even these represent selected study populations. Requesting before-and-after photos directly from a potential provider, rather than from manufacturer websites, yields more relevant information.
Why Men Researching Penuma Photos Are Increasingly Choosing Non-Surgical Enhancement
Male cosmetic procedures have increased 500% over 25 years, growing from 3% to over 15% of cosmetic patients. Growth is increasingly concentrated in non-surgical modalities.
Approximately 12% of the male population perceives their penis to be small, and an estimated 3.6% of those men may ultimately seek enhancement procedures—a significant population making high-stakes decisions.
Men most likely to choose filler over surgery are not those who lack options. They are informed professionals who have conducted thorough research and concluded that the surgical risk/reward ratio does not justify the outcome differential.
The SMSNA’s IRB-only recommendation, post-explant complication data, and 6–8 week recovery requirement are increasingly accessible in peer-reviewed literature—and increasingly influencing patient decisions.
The 89% satisfaction rate in the 2025 HA filler study, combined with no serious adverse events and full reversibility, represents a compelling alternative for men who want results without permanent surgical commitment.
Stoller Medical Group’s 15,000+ procedure experience and staged treatment protocol provide the clinical infrastructure that makes non-surgical outcomes credible and consistent.
What the Stoller Medical Group Approach Offers
Stoller Medical Group’s before-and-after gallery shows real, clinically documented results from filler phalloplasty.
What the photos show: Immediate visible enhancement, natural appearance in both flaccid and erect states, up to 1–1.5 inches of girth increase, and results that look and feel natural.
What photos cannot show but the clinical record can: 80–90% permanent improvement in girth and volume, 18–24 month result longevity, 10-day recovery timeline, no general anesthesia, no surgical incision, and no risk of post-explant dorsal curvature or penile shortening.
The staged treatment protocol serves as a key differentiator—incremental, precision-based enhancement prioritizing proportion, balance, and natural aesthetics over dramatic single-session changes.
Five locations (Manhattan, Long Island, Albany, Pennsylvania, and Minnesota) and free consultations lower barriers to informed, in-person evaluation. Dr. Roy B. Stoller brings 25+ years in aesthetic medicine, with five years dedicated specifically to non-surgical male enhancement and over 15,000 procedures performed—a volume that establishes genuine clinical authority.
Conclusion: The Most Important Image Is the One Built With Complete Information
Penuma before-and-after photos show real results. However, they represent a curated, incomplete picture of a procedure carrying meaningful surgical risks, a demanding recovery, and potentially permanent post-explant consequences.
A man who has researched this topic thoroughly enough to evaluate clinical photos deserves complete, clinically grounded information—not just a promotional gallery.
The evidence-based case for non-surgical filler enhancement is substantial: comparable girth outcomes (2.5 cm mean increase, 89% satisfaction in peer-reviewed studies), no general anesthesia, 10-day recovery, full reversibility, no risk of post-explant disfigurement, and a safety profile identified as the best available by the 2025 Translational Andrology and Urology review.
The goal was never the photo. It was the confidence, the function, and the quality of life that enhancement can provide. That outcome should be pursued with complete information.
Schedule a Free Consultation
Men who have done the research, understand the risks, and are ready for an expert conversation can schedule a free consultation with Stoller Medical Group at any of five locations: Manhattan, Long Island, Albany, Pennsylvania, or Minnesota.
Key differentiators include 15,000+ procedures performed, a non-surgical approach, natural results, 10-day recovery, a staged treatment protocol, and complete discretion.
Dr. Roy B. Stoller is a board-certified physician with 25+ years in aesthetic medicine and recognized expertise in permanent dermal fillers for penile enhancement. Consultations are medically grounded and conducted without pressure, consistent with the practice’s medical-first philosophy.
